- Home
- CSBR vs HEQ Comparison
CSBR vs HEQ Comparison
Compare CSBR & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- HEQ
- Stock Information
- Founded
- CSBR 1985
- HEQ 2011
- Country
- CSBR United States
- HEQ United States
- Employees
- CSBR N/A
- HEQ N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- HEQ Investment Managers
- Sector
- CSBR Health Care
- HEQ Finance
- Exchange
- CSBR Nasdaq
- HEQ Nasdaq
- Market Cap
- CSBR 111.4M
- HEQ 128.9M
- IPO Year
- CSBR 1986
- HEQ N/A
- Fundamental
- Price
- CSBR $8.33
- HEQ $10.54
- Analyst Decision
- CSBR Strong Buy
- HEQ
- Analyst Count
- CSBR 1
- HEQ 0
- Target Price
- CSBR $12.00
- HEQ N/A
- AVG Volume (30 Days)
- CSBR 39.6K
- HEQ 43.1K
- Earning Date
- CSBR 09-10-2025
- HEQ 01-01-0001
- Dividend Yield
- CSBR N/A
- HEQ 9.78%
- EPS Growth
- CSBR N/A
- HEQ N/A
- EPS
- CSBR 0.46
- HEQ N/A
- Revenue
- CSBR $58,591,000.00
- HEQ N/A
- Revenue This Year
- CSBR $15.11
- HEQ N/A
- Revenue Next Year
- CSBR $7.80
- HEQ N/A
- P/E Ratio
- CSBR $17.71
- HEQ N/A
- Revenue Growth
- CSBR 19.03
- HEQ N/A
- 52 Week Low
- CSBR $3.60
- HEQ $9.08
- 52 Week High
- CSBR $11.99
- HEQ $11.84
- Technical
- Relative Strength Index (RSI)
- CSBR 64.00
- HEQ 48.61
- Support Level
- CSBR $7.16
- HEQ $10.45
- Resistance Level
- CSBR $9.63
- HEQ $10.73
- Average True Range (ATR)
- CSBR 0.64
- HEQ 0.08
- MACD
- CSBR 0.11
- HEQ -0.01
- Stochastic Oscillator
- CSBR 69.06
- HEQ 47.22
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.